By all accounts, the past seven months have been among the most challenging Affymetrix has faced since it was founded 15 years ago.

Since August, the 1,101-employee company has faced the dual challenges of launching three major products — the Human Mapping 500K Array set for genotyping, exon arrays, and tiling arrays — and experiencing a manufacturing malfunction that forced it to revise two quarterly earnings forecasts just weeks before the company was set to report its results (see BAN 1/10/2006>, BAN 10/05/2005).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.